Your browser doesn't support javascript.
loading
Dopamine D1R Receptor Stimulation as a Mechanistic Pro-cognitive Target for Schizophrenia.
Abi-Dargham, Anissa; Javitch, Jonathan A; Slifstein, Mark; Anticevic, Alan; Calkins, Monica E; Cho, Youngsun T; Fonteneau, Clara; Gil, Roberto; Girgis, Ragy; Gur, Raquel E; Gur, Ruben C; Grinband, Jack; Kantrowitz, Joshua; Kohler, Christian; Krystal, John; Murray, John; Ranganathan, Mohini; Santamauro, Nicole; Van Snellenberg, Jared; Tamayo, Zailyn; Wolf, Daniel; Gray, David; Lieberman, Jeffrey.
Afiliação
  • Abi-Dargham A; Department of Psychiatry, Stony Brook Renaissance School of Medicine, Stony Brook, NY, USA.
  • Javitch JA; Department of Psychiatry, New York State Psychaitric Institute, Columbia University, New York, NY, USA.
  • Slifstein M; Department of Psychiatry, Yale University, New Haven, CT, USA.
  • Anticevic A; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Calkins ME; Cerevel Therapeutics Research and Development, Boston, MA, USA.
  • Cho YT; Department of Psychiatry, New York State Psychaitric Institute, Columbia University, New York, NY, USA.
  • Fonteneau C; Department of Psychiatry, Stony Brook Renaissance School of Medicine, Stony Brook, NY, USA.
  • Gil R; Department of Psychiatry, Yale University, New Haven, CT, USA.
  • Girgis R; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Gur RE; Department of Psychiatry, Yale University, New Haven, CT, USA.
  • Gur RC; Department of Psychiatry, Yale University, New Haven, CT, USA.
  • Grinband J; Department of Psychiatry, Stony Brook Renaissance School of Medicine, Stony Brook, NY, USA.
  • Kantrowitz J; Department of Psychiatry, New York State Psychaitric Institute, Columbia University, New York, NY, USA.
  • Kohler C; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Krystal J; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Murray J; Department of Psychiatry, New York State Psychaitric Institute, Columbia University, New York, NY, USA.
  • Ranganathan M; Department of Psychiatry, New York State Psychaitric Institute, Columbia University, New York, NY, USA.
  • Santamauro N; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Van Snellenberg J; Department of Psychiatry, Yale University, New Haven, CT, USA.
  • Tamayo Z; Department of Psychiatry, Yale University, New Haven, CT, USA.
  • Wolf D; Department of Psychiatry, Yale University, New Haven, CT, USA.
  • Gray D; Department of Psychiatry, Stony Brook Renaissance School of Medicine, Stony Brook, NY, USA.
  • Lieberman J; Department of Psychiatry, Yale University, New Haven, CT, USA.
Schizophr Bull ; 48(1): 199-210, 2022 01 21.
Article em En | MEDLINE | ID: mdl-34423843
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Receptores de Dopamina D1 / Agonistas de Dopamina / Disfunção Cognitiva / Desenvolvimento de Medicamentos Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Receptores de Dopamina D1 / Agonistas de Dopamina / Disfunção Cognitiva / Desenvolvimento de Medicamentos Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article